SCHEMBL28056841

SCHEMBL28056841

CCC(C)(C)OC(=O)C1CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRB2 P47870 1/20 0.41
GABRA4 P48169 1/20 0.41
GABRE P78334 1/20 0.41
PMP22 Q01453 1/20 0.41
GABRA6 Q16445 1/20 0.41
GABRG1 Q8N1C3 1/20 0.41
GABRG3 Q99928 1/20 0.41
GABRQ Q9UN88 1/20 0.41
GNAI3 P08754 3/20 0.37
GNAO1 P09471 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5363097 0.87 HRH3 (0.36) TSHRMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL16051286 0.86 GABRP (0.41) TSHRGABRPGABRDGABRA1GABRB1
SCHEMBL1376080 0.86 GABRP (0.41) TSHRGABRPGABRDGABRA1GABRB1
SCHEMBL363474 0.86 GABRP (0.41) TSHRGABRPGABRDGABRA1GABRB1
SCHEMBL6461604 0.84 GABRP (0.39) TSHRGABRPGABRDGABRA1GABRB1
SCHEMBL8041931 0.84 GABRP (0.39) TSHRGABRPGABRDGABRA1GABRB1
Hydrochloric Acid SCHEMBL16054755 0.84 GABRP (0.39) TSHRGABRPGABRDGABRA1GABRB1
SCHEMBL5722404 0.83 ADRB2 (0.41) TSHRMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL8908671 0.83 GABRP (0.38) TSHRGABRPGABRDGABRA1GABRB1
SCHEMBL2423420 0.83 GABRP (0.38) TSHRGABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109369635-B Compound or pharmaceutically acceptable salt thereof, application thereof and pharmaceutical composition 赛克里翁治疗有限公司 2023-06-30 CN disclosed
CN-109384778-B Use of a compound or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of a disease, health condition or disorder 赛克里翁治疗有限公司 2022-12-13 CN disclosed
CN-110016020-B Compound or pharmaceutically acceptable salt thereof, application and pharmaceutical composition thereof 赛克里翁治疗有限公司 2022-07-26 CN disclosed
CN-108912111-B Compounds and pharmaceutical compositions 赛克里翁治疗有限公司 2021-09-14 CN disclosed
CN-105408328-A sGC stimulators IRONWOOD PHARMACEUTICALS INC 2016-03-16 CN disclosed